| Literature DB >> 35115946 |
Yanchun Wang1, Junxuan Wu2, Dawei Wang2, Rongyuan Yang3, Qing Liu3.
Abstract
Heart failure (HF) is the terminal stage of multifarious heart diseases and is responsible for high hospitalization rates and mortality. Pathophysiological mechanisms of HF include cardiac hypertrophy, remodeling and fibrosis resulting from cell death, inflammation and oxidative stress. Heat shock proteins (HSPs) can ameliorate folding of proteins, maintain protein structure and stability upon stress, protect the heart from cardiac dysfunction and ameliorate apoptosis. Traditional Chinese medicine (TCM) regulates expression of HSPs and has beneficial therapeutic effect in HF. In this review, we summarized the function of HSPs in HF and the role of TCM in regulating expression of HSPs. Studying the regulation of HSPs by TCM will provide novel ideas for the study of the mechanism and treatment of HF.Entities:
Keywords: heart failure; heat shock proteins; myocardial injury; therapeutic targets; traditional Chinese medicine
Year: 2022 PMID: 35115946 PMCID: PMC8804377 DOI: 10.3389/fphar.2021.814243
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
FIGURE 1The functions of heat shock proteins in HF. Small HSPs (HSP27, HSP20, HO-1), HSP60, HSP70, HSP90, and HSP110 are the most studied HSPs in HF. They can affect apoptosis, inflammation, oxidative stress, fibrosis, contractile function, hypertrophy, ER stress and mitochondrial function by regulating multiple pathways like Akt, caspase-3, ERK and various cellular functions like ER and mitochondria in the progression of HF, including modulating the systolic and diastolic function and the stiffness and enlargement of ventricle.
The functions of heat shock proteins in heart failure.
| HSP family | Function | Model | Protective/adverse effects of HSPs in HF | Ref |
|---|---|---|---|---|
| HSP110 | HSPA4 deletion leads to cardiac hypertrophy and fibrosis | HSPA4 knockout mice that subjected to transverse aortic constriction and volume overload | protective |
|
| HSP90 | Inhibition of HSP90 improves cardiac function | Rats that subjected to CAL. | adverse |
|
| HSP90 can regulate cardiac hypertrophy and collagen deposition | Mice overexpression of HSP75 (a member of HSP90 family located in the mitochondria) | adverse |
| |
| HSP90 facilitates regulation of Raf/Mek/ERK, TGF-β and NF-κB pathways in cardiac hypertrophy | Mice overexpression of HSP75 | adverse |
| |
| Interacts with TGFβ receptor-II and exerts profibrotic effect | Rats that subjected to renal artery ligation; Cardiac fibroblasts that subjected to Ang II and Celastrol | adverse |
| |
| Interacts with IKK complex, leads to NF-κB activation | Ang II-induced cardiac myocytes | adverse |
| |
| HSP75 downregulates TAK, p38, JNK, and Akt phosphorylation levels | Cardiac-specific HSP75 transgenic mice that subjected to aortic banding | protective |
| |
| HSP70 | Maintains cardiac contractility and calcium handling | HSP70-konckout mice that subjected to I/R | protective |
|
| Inhibits p53 activation and its downstream bax, caspase-3 and caspase-9 | DOX-induced HSP70 overexpress transgenic mice | protective |
| |
| Does not improve cardiac function in failing hearts with atrial fibrillation | Cardiac-specific MURC mice and MURC-HSP70 mice | Undetermined |
| |
| Both intracellular and extracellular HSP70 regulates myocardial hypertrophy, cardiac dysfunction and cardiac fibrosis | Mice that subjected to abdominal aortic constriction (AAC) | adverse |
| |
| Extracellular HSP70 promotes cardiac hypertrophy and fibrosis | Mice that subjected to abdominal aortic constriction (AAC) | adverse |
| |
| Extracellular HSP70 activates TLR2 signaling | TLR2/4 knockout mice that subjected to transverse aortic constriction (TAC). Mice treated with anti-HSP70 antibody and DOX. | adverse |
| |
| GRP78 attenuates ER stress and cell death | Neonatal cardiomyocytes that subjected to MG132, epoxomicin or tunicamycin | protective |
| |
| HSP60 | Inhibits caspase-3 activation, interacts with bax and bcl-x | HSP60 and HSP10 overexpressed myocytes that subjected to DOX. | protective |
|
| Interacts with bak and bax in cytoplasm | Myocytes that subjected to antisense phosphorothioate oligonucleotide to reduce HSP60 | protective |
| |
| Maintains mitochondrial homeostasis function | Cardiac-specific HSP60 knockout mice | protective |
| |
| Extracellular HSP60 activates TLR4 and triggers inflammation | Cardiomyocytes of rats that subjected to LAD. | adverse |
| |
| small HSPs—HSP27 | Enhances the SOD activity, increases cell survival | DOX-induced cardiac H9c2 cells and mouse embryonic fibroblasts | protective |
|
| Improves cardiac function, suppresses oxidative stress and decreases apoptosis | DOX-induced cardiac specific-overexpressed HSP27 mice | protective |
| |
| Increases phosphorylation of Akt and GSK-3β, decreases NF-κB activation | LPS-induced cardiac-specific expression of Hsp27 and H9c2 | protective |
| |
| Preserves mitochondrial function | Rats that subjected to coronary artery ligation (CAL) | protective |
| |
| Interacts with SIRT1; increases p53 acetylation and bax when be downregulated | Transfected H9c2 cells that subjected to DOX. | protective |
| |
| High level HSP27 causes reductive stress and develops cardiac dysfunction | HSP27 transgenic mice | adverse |
| |
| Binds to p53 and increases bax contents | DOX-induced HSF-1 knockout mice | protective |
| |
| small HSPs—HSP20 | HSP20 reverse cardiac remodeling, fibrosis and hypertrophy | ISO-induced cardiac-specific overexpressed HSP20 mice and H9c2 cells | protective |
|
| Ameliorates cardiac dysfunction and suppresses ASK1 activation | ISO-induced cardiac-specific overexpressed HSP20 mice and H9c2 cells | protective |
| |
| Inhibits NF-κB activation and caspase-3 activity | LPS-induced Ad. HSP20-AS-infected rat cardiomyocytes | protective |
| |
| Preserves Akt activation, improves cardiac function | DOX-induced cardiac-specific overexpressed HSP20 mice | protective |
| |
| small HSPs—HO-1 | Reduces oxidative stress and preserves mitochondrial function | Cardiac-specific HO-1 transgenic mice that subjected to CAL. | protective |
|
| Preserves cardiac function | AAV-human HO-1 treated rats that subjected to LAD. | protective |
| |
| Increases Akt activation and decreases apoptosis | Ang II-induced myocytes that transfected with human HO-1 | protective |
| |
| Exerts either protective or detrimental effect | Cardiac-specific HO-1 mice that subjected to either TAC or ISO. | Dual |
|
FIGURE 2The regulation of Traditional Chinese Medicine on heat shock proteins. Traditional Chinese medicine (TCM) can exert various biological functions like anti-apoptosis, pro-apoptosis and inhibition of cell proliferation, anti-oxidant, anti-inflammatory response, modulation of ER stress and other properties via regulating HSPs.
The regulation of Traditional Chinese Medicine on heat shock proteins.
| Property | TCM or active ingredients | Targets | Model | Ref |
|---|---|---|---|---|
| Anti-apoptosis | Resveratrol | ↑ HSP27 | Ultraviolet B-treated HaCaT cells |
|
| Hydroxysafflor yellow A, extract of | ↓ phosphorylation of HSP27 at ser 78 | Heat stress-induced neural stem cells |
| |
| Zanthoxylum bungeanum Maxim | ↑ HO-1 | D-Galactose-Induced Aging Mice |
| |
| Icariin | ↑ HSP70 | Calvaria osteoblasts of rats |
| |
| EGb761, extract of Ginkgo biloba leaves | ↑ HSP70 and GRP78 | Aβ1-42 oligomer-induced SH-SY5Y cells |
| |
| Ginsenosides Rg1 and Rb1 (extracts of | ↑ HSP70 | MCAO mice |
| |
| Tanshinone IIA | ↑ HSP70 | Rats that subjected to spinal I/R injury |
| |
| Gualou Guizhi decoction | ↑ HSP70 | Rats that subjected to MCAO. |
| |
| Qinghuobaiduyin formula | ↑ HSP70 | Rats that subjected to burn injury |
| |
| Xiaotan Tongfu granule | ↑ HSP70 | Rats that subjected to cold-restraint model |
| |
| Pro-apoptosis and inhibit cells proliferation | Barbaloin, extract of | ↓ HSP27 | NSCLC cell line A549 |
|
| Lariciresinol | ↓ HSP27 | HepG2 cells |
| |
| Bufalin | ↓ HSP27 | Pancreatic cancer cells |
| |
| Tanshinone IIA, extract of | ↑ phosphorylation of HSP27 at ser 82 | Human gastric cell line AGS |
| |
| Curcumin, extract of | ↓ HSP27 | Human colon cancer HCT-8 and HCT-8/5-FU (5-FU-resistant cell line) |
| |
| Synergistic application of triptolide and celastrol | ↓ HSP27, HSP70 and HSP90 | Human cancer cell lines and human normal embryonic kidney cell line HEK293T |
| |
| Homogeneous | ↓ HSP90 | HepG2 cells |
| |
| Patrinia heterophylla | ↓ HSP90 | Leukemia K562 cells |
| |
| Platycodin D, extract of | ↓ Hsp90/Cdc37 interactions | Human lung cancer cells |
| |
| Anti-oxidative property | Zanthoxylum bungeanum Maxim | ↑ HO-1 | D-Galactose-Induced Aging Mice |
|
| Celastrol (extract of | ↑ HO-1 and HSP70 | Lipopolysaccharide (LPS)-induced rats |
| |
| Protopanaxtriol | ↑ HO-1 and HSP70 | Rats that subjected to 3-nitropropionic acid |
| |
| Radix Bupleuri extract | ↑ HO-1, ↓ HSP70 | H2O2-induced Tilapia |
| |
| Water extract and ethanol extract of | ↑ HO-1 | Cisplatin-induced mouse |
| |
| Diethyl blechnic, a compound isolated from Danshen | ↑ HO-1 | LPS-induced RAW264.7 cells |
| |
| Anti-inflammation | Celastrol, extract of | ↑ HO-1 and HSP70 | LPS-induced rats |
|
| Radix Bupleuri extract | ↑ HO-1, ↓ HSP70 | H2O2-induced Tilapia |
| |
| Momordica grosvenori | ↑ HO-1 | LPS-induced RAW264.7 cells |
| |
| Liquiritigenin and liquiritin | ↓ extracellular release of HSP60 | Monocrotaline-induced Hepatic sinusoidal obstruction syndrome in rats |
| |
| Rhodiola rosea L. root and rhizome extract | ↑ HSP70 | CRH-stimulated BV2 microglial cells |
| |
| Xiaotan Tongfu granule | ↑ HSP70 | Rats that subjected to cold-restraint model |
| |
| Emodin-8-O-glucuronic acid, isolated from qinghuobaiduyin decoction | ↑ HSP70 | LPS-stimulated raw 264.7 cells |
| |
| Modulate ER stress | Bitter melon | ↓ GRP78 | Human colonic adenocarcinoma LS174T cells |
|
| Gambogenic acid, a compound of | ↓ GRP78 | Human nasopharyngeal carcinoma cells |
| |
| Glycyrrhetinic acid, a component of | ↑ GRP78 | Human NSCLC cells |
| |
| Rhein, a compound of rhubarb | ↓ GRP78 | MCF-7 and HepG2 cells |
| |
| Xuefuzhuyu capsules | ↓ GRP78 | Rats subjected to hindlimb unload |
| |
| Bushen Zhuangjin decoction | ↓ GRP78 | Tunicamycin induced-articular chondrocytes |
| |
| Others | Licorice, extract of Glycyrrhiza uralensis Fisch | ↓ phosphorylation of HSP27, alters the interaction of HSP27 and actin | Oxytocin-induced uterine contraction |
|
| Schisandrin B, isolated from a | ↑ HSP27 and HSP70 | D-galactosamine-induced liver injury in mice |
| |
| Combination use of ferulic acid, ligustrazine and tetrahydropalmatine | ↓ HSP90 | Endometriosis rats |
| |
| Uncaria rhynchophylla | ↓ HSP90 | MPP+ -induced SHSY5Y cells and MPTP-induced mice |
| |
| Zhenbao Pill | ↑ HSP27 | Rats that subjected to acute spinal cord injury |
| |
| YangZheng XiaoJi formula | ↓ phosphorylation of HSP27 | Human gastric cancer, pancreatic cancer, ovarian cancer), lung cancer, breast cancer, prostate cancer, ovarian cancer cells |
|
FIGURE 3Traditional Chinese Medicine that target heat shock proteins in myocardial injuries. Components like icariin, astragaloside IV, berberine and decoctions like Baoyuan decoction and Buying Huanwu decoction can alleviate myocardial injury via anti-apoptosis, anti-oxidation, reducing ER stress and cardiac remodeling by regulating the expression of HSPs.
Traditional Chinese Medicine that target heat shock proteins in myocardial injuries.
| Target | TCM | Function | Model | Ref |
|---|---|---|---|---|
| HSP20 | Icariin | Upregulates HSP20 and suppresses apoptosis | H9C2 with H/R |
|
| HO-1 | Astragaloside IV, a component of | Activates Nrf2/HO-1 pathway, attenuates cardiac hypertrophy, improves left ventricular function and structure | Abdominal aortic constriction (AAC)-induced rats; Ang II-induced cardiomyocyte |
|
| Tongxinluo | Upregulates cardiac expression of HO-1 and activates VEGF/Akt/eNOS pathway | TAC-induced HF in mice |
| |
| CRYAB | Baoyuan decoction | Activates CRYAB to inhibit apoptosis, rescues cardiac function | Rats that subjected to LAD; LPS-induced RAW 264.7 Cell; macrophage-conditioned media-stimulated H9C2 cells |
|
| GRP78 | Berberine, Coptis chinensis | Reduce apoptosis and ER stress, improve cardiac function and remodeling | Rats that subjected to LAD. |
|
| Shikonin | Inhibits α-SMA/collagen, TLR4/NF-κB signaling and ER stress pathway, decreases GRP78 | ISO-induced mice and H9C2 cells |
| |
| Aralia elata (Miq) Seem | Alleviates ER stress-induced apoptosis, reduces GRP78 | Rats that subjected to LAD. |
| |
| Panax quinquefolium | Inhibits excessive ER stress and reduces GRP78 | H/R-induced Ventricular cardiomyocytes |
| |
| Araloside C | Attenuates ER stress-dependent apoptotic pathways | H/R-induced H9C2 cells. I/R-induced rat hearts |
| |
| HSP90 | Araloside C | Reduces apoptosis by increasing HSP90 expression | H/R-induced H9C2 cells. I/R-induced rat hearts |
|
| Myricitrin | Increases expression of HSP90 to alleviate apoptosis and oxidative stress | H/R-induced H9C2 cells |
| |
| HSPB6 | Buyang Huanwu decoction | Increases the expression and phosphorylation of HSPB6, ameliorates ventricular remodeling | Rats with left anterior descending (LAD) artery ligation |
|